Basket

0561287 - ÚMG 2023 RIV CH eng J - Journal Article
Talianova, V. - Kejik, Z. - Kaplánek, R. - Veselá, K. - Abramenko, N. - Lacina, L. - Strnadová, K. - Dvořánková, B. - Martásek, P. - Masarik, M. - Houdová Megová, M. - Bušek, P. - Křížová, J. - Zdražilová, L. - Hansíková, H. - Vlčák, Erik - Filimonenko, Vlada - Šedo, A. - Smetana, K. - Jakubek, M.
New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity.
Pharmaceutics. Roč. 14, č. 8 (2022), č. článku 1712. E-ISSN 1999-4923
R&D Projects: GA MŠMT(CZ) EF16_019/0000785; GA MŠMT LX22NPO5102; GA MŠMT(CZ) LM2018129; GA MŠMT(CZ) EF18_046/0016045; GA MŠMT(CZ) EF16_013/0001775
Research Infrastructure: EATRIS-CZ III - 90133
Institutional support: RVO:68378050
Keywords : IL-6R synthetic inhibitors * mitochondria * cancer
OECD category: Pharmacology and pharmacy
Impact factor: 5.4, year: 2022
Method of publishing: Open access
https://www.mdpi.com/1999-4923/14/8/1712
Permanent Link: https://hdl.handle.net/11104/0333975